Detail Information of Xenobiotics-driven Alterations in 3D Complexes
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0022 Transporter Info | ||||
| Gene Name | SLC15A2 | ||||
| Transporter Name | Peptide transporter 2 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
| Xenobiotic Name | Benzylpenicillin Drug Info | ||||
| Xenobiotic Type | Drug in Phase 3 Trial | ||||
| MOA | Inhibition | ||||
| PubChem CID | 5904 | ||||
| Docking Score | -6.86 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C16H18N2O4S | ||||
| Molecular Weight | 334.4 | ||||
| Canonical SMILES |
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C
|
||||
| InChI |
InChI=1S/C16H18N2O4S/c1-16(2)12(15(21)22)18-13(20)11(14(18)23-16)17-10(19)8-9-6-4-3-5-7-9/h3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22)/t11-,12+,14-/m1/s1
|
||||
| InChIKey | JGSARLDLIJGVTE-MBNYWOFBSA-N | ||||
| Pharmaceutical Properties | Xlogp | 1.8 | Rotatable Bond Count | 4 | |
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 5 | ||
| Xenobiotic Name | Dicloxacillin Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 18381 | ||||
| Docking Score | -6.838 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C19H17Cl2N3O5S | ||||
| Molecular Weight | 470.3 | ||||
| Canonical SMILES |
CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O
|
||||
| InChI |
InChI=1S/C19H17Cl2N3O5S/c1-7-10(12(23-29-7)11-8(20)5-4-6-9(11)21)15(25)22-13-16(26)24-14(18(27)28)19(2,3)30-17(13)24/h4-6,13-14,17H,1-3H3,(H,22,25)(H,27,28)/t13-,14+,17-/m1/s1
|
||||
| InChIKey | YFAGHNZHGGCZAX-JKIFEVAISA-N | ||||
| Pharmaceutical Properties | Xlogp | 2.9 | Rotatable Bond Count | 4 | |
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 7 | ||
| Xenobiotic Name | Cefmetazole Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 42008 | ||||
| Docking Score | -6.584 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C15H17N7O5S3 | ||||
| Molecular Weight | 471.5 | ||||
| Canonical SMILES |
CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)CSCC#N)OC)SC2)C(=O)O
|
||||
| InChI |
InChI=1S/C15H17N7O5S3/c1-21-14(18-19-20-21)30-6-8-5-29-13-15(27-2,17-9(23)7-28-4-3-16)12(26)22(13)10(8)11(24)25/h13H,4-7H2,1-2H3,(H,17,23)(H,24,25)/t13-,15+/m1/s1
|
||||
| InChIKey | SNBUBQHDYVFSQF-HIFRSBDPSA-N | ||||
| Pharmaceutical Properties | Xlogp | -0.6 | Rotatable Bond Count | 9 | |
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 12 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.